Skip to main content
HR 3680 114th Congress House Health Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health programs administration and funding Prescription drugs State and local government operations

Co-Prescribing to Reduce Overdoses Act of 2016

Introduced: October 1, 2015 See on congress.gov
 Everywhere this bill has been 19 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 12, 2016
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 11, 2016
Motion to reconsider laid on the table Agreed to without objection.
May 11, 2016
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
May 11, 2016
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2256-2257)
May 11, 2016
DEBATE - The House proceeded with forty minutes of debate on H.R. 3680.
May 11, 2016
Considered under suspension of the rules. (consideration: CR H2256-2259)
May 11, 2016
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2256-2257)
May 10, 2016
Placed on the Union Calendar, Calendar No. 427.
May 10, 2016
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-553.
Apr 28, 2016
Ordered to be Reported (Amended) by Voice Vote.
Apr 28, 2016
Committee Consideration and Mark-up Session Held.
Apr 27, 2016
Committee Consideration and Mark-up Session Held.
Apr 26, 2016
Committee Consideration and Mark-up Session Held.
Apr 25, 2016
Committee Consideration and Mark-up Session Held.
Apr 20, 2016
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 20, 2016
Subcommittee Consideration and Mark-up Session Held.
Oct 2, 2015
Referred to the Subcommittee on Health.
Oct 1, 2015
Referred to the House Committee on Energy and Commerce.
Oct 1, 2015
Introduced in House
 Plain-English summary Congressional Research Service

Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.

What's happening now May 12, 2016

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3